Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

283 trials

NCT02393157
Recruiting
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT01137825
Recruiting
Registry of Older Patients With Cancer
Not applicable · United States · 7 sites
Registry update: 29 Jun 2026
NCT01137643
Recruiting
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Not applicable · United States · 1 site
Registry update: 28 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL